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Summary The assessment of a tumour's angiogenic potential, by measuring the microvessel density in histological sections, assumes that
a 4-,um section is representative of whole tumour vascularity. This study has examined this assumption by comparing the vessel density found
radiologically, after injecting specimens with contrast, with that found immunohistochemically. Twenty-one breast angiograms were performed
following mastectomy for carcinoma and graded 1-3 for vessel density. Sections (4 jm) from these carcinomas were labelled for endothelial
cells using anti-CD34, and the vessel counts were compared with the radiological grades. A significant correlation was found between the
densities (P< 0.003, Kruskal-Wallis one-way ANOVA). We therefore conclude that the microvessel density measured in histological sections
is representative of whole tumour vascularity.
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High tumour vascularity in breast cancer has been shown to corre-
late with poor prognosis (Bosari et al, 1992; Horak et al, 1992;
Weidner et al, 1992) and has been suggested as both a useful prog-
nostic indicator (Toi et al, 1993) and a tool for identifying those
lymph node-negative breast cancer patients who might benefit
from adjuvant chemotherapy (Gasparini et al, 1995). Not all
studies however have found a correlation between vascularity and
outcome (Van Hoef et al, 1993; Hall et al, 1992; Axelsson et al,
1995). One possible reason for this might be the sampling
error inherent in the immunohistochemical technique used for
microvessel density quantification. Such techniques, of necessity,
look at only a tiny proportion ofthe tumour in a 4-gm histological
section and assume that this is representative of whole tumour
vascularity. Considerable heterogeneity has been found, however,
within a section and between sections taken from different blocks
of the same tumour (Weidner et al, 1991; Bosari et al, 1992; Van
Hoefet al, 1993; De Jong et al, 1995).
This study examines the relationship between vascularity,
assessed by a standard immunohistochemical technique, and an
estimate ofwhole tumour vasculature, assessed by the novel tech-
nique of breast microangiography. This allows study not only of
vessel numbers but also of morphology and pattern. Using this
technique, we have compared the radiological density with stan-
dard immunohistochemical data on multiple sections throughout
the tumour. This new technique ofvascular imaging has also clari-
fied whether 'hot-spots' can be assessed in any part of the tumour
or only at the leading edge; in addition, it has led to interesting
speculation on the possible mechanisms oftumour metastasis.
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MATERIALS AND METHODS
Microangiograms were performed on patients undergoing modi-
fied radical mastectomy for primary breast cancer at the Royal
Liverpool University Hospital between October 1994 and June
1995. In theatre, immediately following removal of the breast, a
perforating vein in the specimen from the internal mammary or
lateral thoracic vessels was cannulated with a 2-ch catheter
(0.63 mm diameter). A mixture ofbarium, gelatin and formalin at
60°C was injected into the specimen. This mixture is liquid on
injection but sets when cool, leaving a cast in the vessels that can
be visualized both radiologically and histologically. Injection pres-
sure was between 30 and 40 mmHg, and 12-20 ml ofcontrast was
injected depending on the size of the breast. Injection was
continued until contrast could be seen emerging from small vessels
at the opposite side of the specimen. Specimens were then radi-
ographed using a IGE 600T mammogram set withoutcompression.
Following a preliminary screen of all films, the individual
microangiograms were simultaneously subjectively graded 1-3 for
vessel density (1 lowest vessel density, 3 the highest) by three
observers (LM, CH and an independent observer GHW), who all
had to agree on the grade and were blinded to the microvessel
counts and other histological parameters.
Standardhistological parameters ofsize, grade (modified Bloom
and Richardson; Elston and Ellis, 1991), vascular/lymphatic inva-
sion and nodal status were measured. The presence or absence of
Table 1 Angiogram grade and vessel density
Angiogram grade
Number of patients 6 11 4
Mean vessel density per 200 x field 41 77 162
40Heterogeneity oftumourangiogenesis 41
Figure 1 Breast cancer microangiogram demonstrating anastomosing
vascular pattern
Figure 2 Breast cancer microangiogram demonstrating radiating vascular
pattern
Figure 3 Tumour angiogram in patient treated with neoadjuvant
chemotherapy. Histological examination failed to show any residual tumour,
although a typical tumour angiogram remains
barium crystals within vessels on the histological sections was
noted as indicating that a vessel had been filled by the injection.
Four-micron sections were stained with anti-CD34, a mono-
clonal antibody to a transmembrane protein found on immature
Figure 4 Immunohistological section taken from tumour centre, labelled with
anti-CD34, showing barium crystals within vessels, suggesting that they are
functional
Figure 5 Haematoxylin and eosin section showing vascular/lymphatic
invasion with vessels containing either tumour cells or crystals of contrast
medium but not both in the same vascular channel
endothelial cells, using a standard immunoperoxidase technique.
The stained sections were scanned at low magnification (x 40 and
x 100) to identify the areas of most intense neovascularization
(or tumour 'hot spots') and, once identified, point counting
was performed of labelled cells as described by Weidner et al
(1991). Ten fields were counted at 200 x magnification (field size
0.68 mm2) for each tumour and the highest value was taken for
further statistical analysis. Vascular heterogeneity was assessed by
labelling sections from three different blocks for each tumour, one
from each end and one from the centre. Our inter-observer error is
less than 10% and therefore a variation in vessel count of 20% or
more between blocks was considered to be significant.
RESULTS
Twenty-five angiograms were performed. There were four tech-
nical failures: in three no vessel could be cannulated and in one
there was gross extravasation ofcontrast.
The mean age of the patients was 62 years (median 64, range
44-87). The mean tumour size was 32 mm (median 29.5 mm,
range 17-60 mm). Five patients had a histological grade I tumour,
nine a grade II tumour and six patients a grade III tumour (one
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patient had received neoadjuvant chemotherapy and histologically
had no evidence of residual tumour). Twelve patients were node
positive, seven were node negative and no information was avail-
able for two patients. The mean vessel count, measured immuno-
histochemically, was 85 vessels per 200 x field (median 66, range
30-262, s.d. 59).
Heterogeneity
Vessel counts among three blocks varied by less than 20% in 14 of
20 cases (70%).
Angiographic vessel density
Six angiograms were graded I, 11 were graded II and four were
graded III for vessel density.
The immunohistochemical vascular counts correlated well with
the angiogram grade (P < 0.003, Kruskal-Wallis one-way Anova)
(Table 1).
Vascular pattern
Two distinct vascular patterns were identified - an anastomosing
pattern with numerous branching anastomoses (Figure 1) and a
radial pattern with few apparent anastomoses within the tumour
(Figure 2). Fifteen angiograms showed the anastomotic pattern,
four showed the radiating pattern and in two there was not a
distinct pattern. The radiating pattern was not caused by tumour
sclerosis and did not correlate with any other histological para-
meter or with vessel density.
One patient had been treated with neoadjuvant chemotherapy,
and histological examination after mastectomy failed to show any
residual tumour within the breast, although the patient was node
positive. Despite the impressive histological response a typical
'tumour angiogram' remained (Figure 3).
Histological distribution
Barium crystals were seen in vessels as small as 8 ,um in diameter
on the haematoxylin and eosin sections, and vessels throughout the
tumour, including the centre, contained barium crystals (Figure 4).
Vascular/lymphatic invasion was present in sections from eight
of the mastectomy specimens. However, contrast medium and
tumour cells were not seen in the same vessel in any of the
sections, although vessels full of tumour and vessels full of
contrast were seen in close proximity (Figure 5).
DISCUSSION
The correlation between whole tumour vascularity determined by
microangiography and the vascular count measured immunohisto-
chemically on a 4-im section suggests that the standard technique,
as described by Weidner et al (1991), gives a good assessment of
overall tumour vascularity.
It has been stated (Van Hoef et al, 1993) that tumour hetero-
geneity may introduce a considerable error in the assessment of
vascular density as based on the technique described by Weidner et
al (1991). Firstly, the area of greatest vascularity or 'tumour hot-
spot', may not always be apparent (Bosari et al, 1992; Axelsson et
al, 1995). This may be addressed by either increasing the training
period on angiogenesis assessment (Vermeulen et al, 1995;
Simpson et al, 1996) or by counting the ten apparent highest fields
and taking the highest count, as in this study. Once the 'hot-spots'
have been identified, further subjectivity can be reduced by the use
of a Chalkey point eyepiece graticule (Fox et al, 1995). Secondly,
although counts taken from serial sections are quite constant (Van
Hoef et al, 1993; De Jong et al, 1995), heterogeneity between
blocks exists. Our results are in agreement with studies by Bosari
et al (1992), Van Hoef et al (1993) and De Jong et al (1995), who
measured vascular density in different blocks from the same
tumour and also found a concordance rate of between 71% and
78%. De Jong et al conclude that because of the heterogeneity
between different blocks from the same tumour, single sections
should be taken from multiple blocks and each should be scanned
to identify the 'hottest-spot' for each tumour. Although we also
found a similar degree of heterogeneity between sections taken
from different blocks, when applying a cut-off value of either the
mean or median to group patients into 'high' and 'low', 17 of 20
patients (85%) would have been correctly assigned to either group
whether one section or multiple sections had been assessed. We
therefore conclude that a tumour's angiogenic potential can be
assessed on one histological section making this technique suitable
for clinical practice.
It has been suggested (Vaupel et al, 1989) that vessels in the
tumour centre degenerate, or become non-functioning, as a result
of the pressure from tumour growth and therefore cannot be
involved in metastasis. If this is so, can tumour 'hot-spots' be
counted in these areas? This study has clearly demonstrated that
vessels in the tumour centre contain contrast (Figure 3) and there-
fore can be functional in vivo.
The radiating vascular pattern has not been previously
described. Its significance is unknown and more angiograms need
to be done before its clinical significance, if any, can be deter-
mined. Current studies are investigating expression of basic fibro-
blast growth factor (bFGF) and vascular endothelial growth factor
(VEGF) to see if variations in these angiogenic factors may
account for the two distinct patterns, and we await longer clinical
follow-up to see ifthere is any survival difference between the two.
Current immunohistochemical markers of neovasculature stain
both blood and lymphatic vessel endothelium, and it is unclear
whether breast cancer metastasizes primarily via lymphatic or
vascular channels or a mixture of both. As observed in the Results
section, we have not found contrast medium and tumour cells
within the same vessel in any section. Tumour spreading via
lymphatics, and not blood vessels, would account for this;
although contrast could have pushed tumour cells out of the
vessels or tumour cells may have blocked the lumen, rendering
them non-functional.
One patient treated with neoadjuvant chemotherapy failed to
show any residual tumour on histological examination despite
being node positive. Despite the impressive histological response,
a typical 'tumour angiogram' remained, indicating that although
the tumour cells had been destroyed by the chemotherapy tumour-
associated vasculature remained. Protopapa et al (1993) reported
an association between increased vascularity and survival after
mastectomy combined with neoadjuvant and adjuvant chemo-
therapy, concluding that this was because of the improved access
of the cytotoxic agents to tumour cells in the more vascularized
tumours. If tumour vascularity could be predicted preoperatively,
those patients with highly vascularized tumours may benefit
from neoadjuvant chemotherapy, followed by the use of an anti-
angiogenic drug. Currently, we are attempting to measure tumour
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vascularity preoperatively in patients planned for mastectomy.
This involves the use of contrast enhancement on magnetic reso-
nance imaging after gadolinium injection and comparison of the
speed ofenhancement with the vessel density found on the tumour
angiograms. This may enable us to stratify those patients who have
a highly vascularized tumour and who may benefit from a more
individualized treatment plan.
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